These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9619731)

  • 1. Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.
    Mitterbauer M; Kusec R; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    Ann Hematol; 1998; 76(3-4):139-43. PubMed ID: 9619731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
    Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
    Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL; Chan V; Wong KF; Chan TK
    Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
    Marcucci G; Livak KJ; Bi W; Strout MP; Bloomfield CD; Caligiuri MA
    Leukemia; 1998 Sep; 12(9):1482-9. PubMed ID: 9737700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing.
    Sarriera JE; Albitar M; Estrov Z; Gidel C; Aboul-Nasr R; Manshouri T; Kornblau S; Chang KS; Kantarjian H; Estey E
    Leukemia; 2001 Jan; 15(1):57-61. PubMed ID: 11243400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia.
    Ishida F; Ueno M; Tanaka H; Makishima H; Suzawa K; Hosaka S; Hidaka E; Ishikawa M; Yamauchi K; Kitano K; Kiyosawa K
    Cancer Genet Cytogenet; 2002 Jan; 132(2):133-5. PubMed ID: 11850074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
    Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
    Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
    Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
    Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
    Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS
    Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission.
    Guerrasio A; Rosso C; Martinelli G; Lo Coco F; Pampinella M; Santoro A; Lanza C; Allione B; Resegotti L; Saglio G
    Br J Haematol; 1995 Jun; 90(2):364-8. PubMed ID: 7794758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
    J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes.
    Taviaux S; Brunel V; Dupont M; Fernandez F; Ferraz C; Carbuccia N; Sainty D; Demaille J; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1999 Feb; 24(2):165-71. PubMed ID: 9885986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ins(8;21) with AML1/ETO fusion in acute myelogenous leukemia M2 by molecular cytogenetics.
    Urioste M; Martínez-Ramírez A; Cigudosa JC; Mateo MS; Martínez P; Contra T; Benítez J
    Cancer Genet Cytogenet; 2002 Feb; 133(1):83-6. PubMed ID: 11890995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes.
    Barragán E; Bolufer P; Moreno I; Martín G; Nomdedeu J; Brunet S; Fernández P; Rivas C; Sanz MA
    Leuk Lymphoma; 2001 Aug; 42(4):747-56. PubMed ID: 11697505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
    Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
    Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.